3-hydroxybutyric acid has been researched along with pioglitazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, LA; Angulo, P | 1 |
| Clore, J; Contos, MJ; Luketic, VA; Mills, AS; Mofrad, PS; Sanyal, AJ; Sargeant, C; Shiffman, ML; Sterling, RK; Stravitz, RT | 1 |
| Fouladi-Nashta, AA; Kohram, H; Yousefi, AR; Zamiri, MJ; Zare Shahneh, A | 1 |
| Matthews, SA; Samson, KK; Simeone, KA; Simeone, TA | 1 |
| Matthews, SA; Simeone, KA; Simeone, TA | 1 |
1 trial(s) available for 3-hydroxybutyric acid and pioglitazone
| Article | Year |
|---|---|
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis.
Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Logistic Models; Male; Middle Aged; Pilot Projects; Pioglitazone; Prospective Studies; Thiazolidinediones; Treatment Outcome; Vitamin E | 2004 |
4 other study(ies) available for 3-hydroxybutyric acid and pioglitazone
| Article | Year |
|---|---|
Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
Topics: 3-Hydroxybutyric Acid; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Fatty Liver; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Pioglitazone; Thiazolidinediones; Vitamin E | 2004 |
Effects of dietary supplementation of pioglitazone on metabolism, milk yield, and reproductive performance in transition dairy cows.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Dietary Supplements; Fatty Acids, Nonesterified; Insulin-Like Growth Factor I; Lactation; Milk; Pioglitazone; Reproduction; Thiazolidinediones; Triglycerides | 2016 |
Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.
Topics: 3-Hydroxybutyric Acid; Age Factors; Anilides; Animals; Animals, Newborn; Anticonvulsants; Blood Glucose; Brain; Convulsants; Diet, Ketogenic; Disease Models, Animal; Drinking; Epilepsy; Flurothyl; Gene Expression Regulation, Developmental; Hypoglycemic Agents; Kv1.1 Potassium Channel; Mice; Mice, Inbred C57BL; Mice, Knockout; Pioglitazone; PPAR gamma; Thiazolidinediones | 2017 |
Synergistic protection against acute flurothyl-induced seizures by adjuvant treatment of the ketogenic diet with the type 2 diabetes drug pioglitazone.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Body Weight; Convulsants; Diet, Ketogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Flurothyl; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Pioglitazone; Reaction Time; Seizures; Thiazolidinediones | 2017 |